Wada T, Kawai A, Ihara K, Sasaki M, Sonoda T, Imaeda T, Yamashita T
Department of Public Health, Sapporo Medical University, Sapporo, Japan.
J Bone Joint Surg Br. 2007 May;89(5):659-63. doi: 10.1302/0301-620X.89B5.18498.
We evaluated the construct validity of the Musculoskeletal Tumour Society rating scale (Enneking score) as a functional measure for patients with sarcoma involving the upper limb. We compared the Enneking score by examining the correlation between two patient-derived outcome measures, the Disability of the Arm, Shoulder, and Hand (DASH) questionnaire and the Medical Outcomes Study Short Form-36 (SF-36) as indicators of functional status in 40 patients with malignant or aggressive benign bone and soft-tissue tumours of the upper limb who had undergone surgical treatment. The frequency distributions were similar among the three scoring systems. As for the validity, Spearman's rank correlation coefficient of the Enneking score to the DASH questionnaire was -0.79 and that of the Enneking to the SF-36 subscales ranged from 0.38 to 0.60. Despite being a measure from the surgeon's perspective, the Enneking score was shown to be a valid indicator of physical disability in patients with malignant or aggressive benign tumours of the upper limb and reflected their opinion.
我们评估了肌肉骨骼肿瘤学会评分量表(Enneking评分)作为上肢肉瘤患者功能指标的结构效度。我们通过检查两种患者源性结局指标之间的相关性来比较Enneking评分,这两种指标分别是上肢、肩部和手部功能障碍(DASH)问卷以及医学结局研究简明健康调查36项量表(SF-36),它们作为40例接受手术治疗的上肢恶性或侵袭性良性骨与软组织肿瘤患者功能状态的指标。三种评分系统的频率分布相似。至于效度,Enneking评分与DASH问卷的Spearman等级相关系数为-0.79,Enneking评分与SF-36分量表的相关系数范围为0.38至0.60。尽管Enneking评分是从外科医生的角度进行衡量,但它被证明是上肢恶性或侵袭性良性肿瘤患者身体残疾的有效指标,并反映了他们的意见。